Steven Sandor - 10 Aug 2022 Form 4 Insider Report for BIOLASE, INC (BIOL)

Role
Chief Operating Officer
Signature
/s/ Michael C. Carroll, attorney-in-fact for Steven Sandor
Issuer symbol
BIOL
Transactions as of
10 Aug 2022
Transactions value $
$0
Form type
4
Filing time
12 Aug 2022, 16:47:08 UTC
Previous filing
14 Jul 2022
Next filing
06 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIOL Restricted Stock Unit Award $0 +15,000 +156% $0 24,644 10 Aug 2022 Common Stock 15,000 Direct F1, F2
transaction BIOL Restricted Stock Unit Award $0 +4,621 +19% $0 29,265 10 Aug 2022 Common Stock 4,621 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 At the option of the Company, each restricted stock unit represents the right to receive, at settlement, one share of common stock, or its cash equivalent.
F2 The restricted stock unit award vests as follows: (i) one-half of the restricted stock units shall vest on the twelve-month anniversary of date of grant, and (ii) one-half of the restricted stock units shall vest on the twenty-fourth month anniversary of the date of grant, subject to the Reporting Person's continued service with the Company.
F3 The restricted stock unit award vests on August 14, 2022, subject to the Reporting Person's continued service with the Company.